title: [Gammaglobulin for idiopathic thrombocytopenia in pregnancy].
abstract: The association of idiopathic thrombocytopenic purpura (ITP) and pregnancy is of special therapeutic significance because it increases the risk to mother and infant during labor. The specific antiplatelet immunoglobulin G (IgG) crosses the placenta and induces thrombocytopenia in the fetus. Intravenous IgG is a new treatment associated with a relatively rapid increase in platelet count. Although this increase is transient, usually lasting only several weeks, the treatment can be repeated a number of times during pregnancy. Knowing the kinetics of platelet response to treatment in the specific patient, it is usually possible to treat so as to maintain a safe platelet count during labor.
authors: C
authors: C
authors: Butnaru
authors: D
authors: D
authors: Zilberman
authors: R
authors: R
authors: Zimlichman
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D011696:Purpura, Thrombocytopenic / Q000628:therapy*